Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen

scientific article

Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/PEC.0B013E3181B0A49A
P698PubMed publication ID19687711

P50authorSandra H. SchwabQ93818764
P2093author name stringRakesh D Mistry
James R Treat
P433issue8
P921main subjectemerging pathogenQ108429945
Stevens–Johnson syndromeQ1053948
toxic epidermal necrolysisQ1878682
P304page(s)519-522
P577publication date2009-08-01
P1433published inPediatric Emergency CareQ15758757
P1476titleStevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen
P478volume25

Reverse relations

cites work (P2860)
Q45353001Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation
Q41961819Oral lesions associated with Nevirapine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A report of 10 cases
Q51020524Stevens-Johnson syndrome in a juvenile systemic lupus erythematosus patient.
Q64043064[What's new in clinical dermatology?]

Search more.